Global Oncology Companion Diagnostic Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 29-Dec-2020
No. of pages: 93
Inquire Before Buying

Oncology Companion Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oncology Companion Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Technology and by End Users in terms of revenue and forecast for the period 2015-2026.

Market segment by Technology, the product can be split into

- Polymerase Chain Reaction (PCR)

- Next-Generation Sequencing (NGS)

- Immunohistochemistry (IHC)

- In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)

- Others

Market segment by End Users, split into

- Hospital

- Pathology/Diagnostic Laboratory

- Academic Medical Center

Based on regional and country-level analysis, the Oncology Companion Diagnostic market has been segmented as follows:

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- Latin America

- - Mexico

- - Brazil

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

In the competitive analysis section of the report, leading as well as prominent players of the global Oncology Companion Diagnostic market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

The key players covered in this study

- Agilent Technologies, Inc.

- Illumina, Inc.

- Qiagen N.V.

- Thermo Fisher Scientific Inc.

- F. Hoffmann-La Roche Ltd.

- ARUP Laboratories

- Abbott

- Myriad Genetics, Inc.

- bioMérieux SA

Global Oncology Companion Diagnostic Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Market Analysis by Technology
1.3.1 Global Oncology Companion Diagnostic Market Size Growth Rate by Technology: 2020 VS 2026
1.3.2 Polymerase Chain Reaction (PCR)
1.3.3 Next-Generation Sequencing (NGS)
1.3.4 Immunohistochemistry (IHC)
1.3.5 In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
1.3.6 Others
1.4 Market by Application
1.4.1 Global Oncology Companion Diagnostic Market Share by End Users: 2020 VS 2026
1.4.2 Hospital
1.4.3 Pathology/Diagnostic Laboratory
1.4.4 Academic Medical Center
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Companion Diagnostic Market Perspective (2015-2026)
2.2 Oncology Companion Diagnostic Growth Trends by Regions
2.2.1 Oncology Companion Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Oncology Companion Diagnostic Historic Market Share by Regions (2015-2020)
2.2.3 Oncology Companion Diagnostic Forecasted Market Size by Regions (2021-2026)
2.3 Oncology Companion Diagnostic Industry Dynamic
2.3.1 Oncology Companion Diagnostic Market Trends
2.3.2 Oncology Companion Diagnostic Market Drivers
2.3.3 Oncology Companion Diagnostic Market Challenges
2.3.4 Oncology Companion Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Companion Diagnostic Players by Market Size
3.1.1 Global Top Oncology Companion Diagnostic Players by Revenue (2015-2020)
3.1.2 Global Oncology Companion Diagnostic Revenue Market Share by Players (2015-2020)
3.2 Global Oncology Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oncology Companion Diagnostic Revenue
3.4 Global Oncology Companion Diagnostic Market Concentration Ratio
3.4.1 Global Oncology Companion Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Companion Diagnostic Revenue in 2019
3.5 Key Players Oncology Companion Diagnostic Area Served
3.6 Key Players Oncology Companion Diagnostic Product Solution and Service
3.7 Date of Enter into Oncology Companion Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Companion Diagnostic Breakdown Data by Technology
4.1 Global Oncology Companion Diagnostic Historic Market Size by Technology (2015-2020)
4.2 Global Oncology Companion Diagnostic Forecasted Market Size by Technology (2021-2026)
5 Oncology Companion Diagnostic Breakdown Data by End Users
5.1 Global Oncology Companion Diagnostic Historic Market Size by End Users (2015-2020)
5.2 Global Oncology Companion Diagnostic Forecasted Market Size by End Users (2021-2026)
6 North America
6.1 North America Oncology Companion Diagnostic Market Size (2015-2026)
6.2 North America Oncology Companion Diagnostic Market Size by Technology (2015-2020)
6.3 North America Oncology Companion Diagnostic Market Size by End Users (2015-2020)
6.4 North America Oncology Companion Diagnostic Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Oncology Companion Diagnostic Market Size (2015-2026)
7.2 Europe Oncology Companion Diagnostic Market Size by Technology (2015-2020)
7.3 Europe Oncology Companion Diagnostic Market Size by End Users (2015-2020)
7.4 Europe Oncology Companion Diagnostic Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Oncology Companion Diagnostic Market Size (2015-2026)
8.2 Asia-Pacific Oncology Companion Diagnostic Market Size by Technology (2015-2020)
8.3 Asia-Pacific Oncology Companion Diagnostic Market Size by End Users (2015-2020)
8.4 Asia-Pacific Oncology Companion Diagnostic Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
9 Latin America
9.1 Latin America Oncology Companion Diagnostic Market Size (2015-2026)
9.2 Latin America Oncology Companion Diagnostic Market Size by Technology (2015-2020)
9.3 Latin America Oncology Companion Diagnostic Market Size by End Users (2015-2020)
9.4 Latin America Oncology Companion Diagnostic Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Companion Diagnostic Market Size (2015-2026)
10.2 Middle East & Africa Oncology Companion Diagnostic Market Size by Type (2015-2020)
10.3 Middle East & Africa Oncology Companion Diagnostic Market Size by Application (2015-2020)
10.4 Middle East & Africa Oncology Companion Diagnostic Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11Key Players Profiles
11.1 Agilent Technologies, Inc.
11.1.1 Agilent Technologies, Inc. Company Details
11.1.2 Agilent Technologies, Inc. Business Overview
11.1.3 Agilent Technologies, Inc. Oncology Companion Diagnostic Introduction
11.1.4 Agilent Technologies, Inc. Revenue in Oncology Companion Diagnostic Business (2015-2020))
11.1.5 Agilent Technologies, Inc. Recent Development
11.2 Illumina, Inc.
11.2.1 Illumina, Inc. Company Details
11.2.2 Illumina, Inc. Business Overview
11.2.3 Illumina, Inc. Oncology Companion Diagnostic Introduction
11.2.4 Illumina, Inc. Revenue in Oncology Companion Diagnostic Business (2015-2020)
11.2.5 Illumina, Inc. Recent Development
11.3 Qiagen N.V.
11.3.1 Qiagen N.V. Company Details
11.3.2 Qiagen N.V. Business Overview
11.3.3 Qiagen N.V. Oncology Companion Diagnostic Introduction
11.3.4 Qiagen N.V. Revenue in Oncology Companion Diagnostic Business (2015-2020)
11.3.5 Qiagen N.V. Recent Development
11.4 Thermo Fisher Scientific Inc.
11.4.1 Thermo Fisher Scientific Inc. Company Details
11.4.2 Thermo Fisher Scientific Inc. Business Overview
11.4.3 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Introduction
11.4.4 Thermo Fisher Scientific Inc. Revenue in Oncology Companion Diagnostic Business (2015-2020)
11.4.5 Thermo Fisher Scientific Inc. Recent Development
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Details
11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Introduction
11.5.4 F. Hoffmann-La Roche Ltd. Revenue in Oncology Companion Diagnostic Business (2015-2020)
11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
11.6 ARUP Laboratories
11.6.1 ARUP Laboratories Company Details
11.6.2 ARUP Laboratories Business Overview
11.6.3 ARUP Laboratories Oncology Companion Diagnostic Introduction
11.6.4 ARUP Laboratories Revenue in Oncology Companion Diagnostic Business (2015-2020)
11.6.5 ARUP Laboratories Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Oncology Companion Diagnostic Introduction
11.7.4 Abbott Revenue in Oncology Companion Diagnostic Business (2015-2020)
11.7.5 Abbott Recent Development
11.8 Myriad Genetics, Inc.
11.8.1 Myriad Genetics, Inc. Company Details
11.8.2 Myriad Genetics, Inc. Business Overview
11.8.3 Myriad Genetics, Inc. Oncology Companion Diagnostic Introduction
11.8.4 Myriad Genetics, Inc. Revenue in Oncology Companion Diagnostic Business (2015-2020)
11.8.5 Myriad Genetics, Inc. Recent Development
11.9 bioMérieux SA
11.9.1 bioMérieux SA Company Details
11.9.2 bioMérieux SA Business Overview
11.9.3 bioMérieux SA Oncology Companion Diagnostic Introduction
11.9.4 bioMérieux SA Revenue in Oncology Companion Diagnostic Business (2015-2020)
11.9.5 bioMérieux SA Recent Development
11.10 Invivoscribe, Inc.
11.10.1 Invivoscribe, Inc. Company Details
11.10.2 Invivoscribe, Inc. Business Overview
11.10.3 Invivoscribe, Inc. Oncology Companion Diagnostic Introduction
11.10.4 Invivoscribe, Inc. Revenue in Oncology Companion Diagnostic Business (2015-2020)
11.10.5 Invivoscribe, Inc. Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Oncology Companion Diagnostic Market Size Growth Rate by Technology (US$ Million): 2020 VS 2026
Table 2. Key Players of Polymerase Chain Reaction (PCR)
Table 3. Key Players of Next-Generation Sequencing (NGS)
Table 4. Key Players of Immunohistochemistry (IHC)
Table 5. Key Players of In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
Table 6. Key Players of Others
Table 7. Global Oncology Companion Diagnostic Market Size Growth by End Users (US$ Million): 2020 VS 2026
Table 8. Global Oncology Companion Diagnostic Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Oncology Companion Diagnostic Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Oncology Companion Diagnostic Market Share by Regions (2015-2020)
Table 11. Global Oncology Companion Diagnostic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Oncology Companion Diagnostic Market Share by Regions (2021-2026)
Table 13. Oncology Companion Diagnostic Market Market Trends
Table 14. Oncology Companion Diagnostic Market Drivers
Table 15. Oncology Companion Diagnostic Market Challenges
Table 16. Oncology Companion Diagnostic Market Restraints
Table 17. Global Oncology Companion Diagnostic Revenue by Players (2015-2020) (US$ Million)
Table 18. Global Oncology Companion Diagnostic Market Share by Players (2015-2020)
Table 19. Global Top Oncology Companion Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Companion Diagnostic as of 2019)
Table 20. Global Oncology Companion Diagnostic by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Oncology Companion Diagnostic Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oncology Companion Diagnostic Market Size by Technology (2015-2020) (US$ Million)
Table 25. Global Oncology Companion Diagnostic Revenue Market Share by Technology (2015-2020)
Table 26. Global Oncology Companion Diagnostic Forecasted Market Size by Technology (2021-2026) (US$ Million)
Table 27. Global Oncology Companion Diagnostic Market Size Share by End Users (2015-2020) (US$ Million)
Table 28. Global Oncology Companion Diagnostic Revenue Market Share by End Users (2015-2020)
Table 29. Global Oncology Companion Diagnostic Forecasted Market Size by End Users (2021-2026) (US$ Million)
Table 30. North America Oncology Companion Diagnostic Market Size by Technology (2015-2020) (US$ Million)
Table 31. North America Oncology Companion Diagnostic Market Share by Technology (2015-2020)
Table 32. North America Oncology Companion Diagnostic Market Size by End Users (2015-2020) (US$ Million)
Table 33. North America Oncology Companion Diagnostic Market Share by End Users (2015-2020)
Table 34. North America Oncology Companion Diagnostic Market Size by Country (US$ Million) (2015-2020)
Table 35. North America Oncology Companion Diagnostic Market Share by Country (2015-2020)
Table 36. Europe Oncology Companion Diagnostic Market Size by Technology (2015-2020) (US$ Million)
Table 37. Europe Oncology Companion Diagnostic Market Share by Technology (2015-2020)
Table 38. Europe Oncology Companion Diagnostic Market Size by End Users (2015-2020) (US$ Million)
Table 39. Europe Oncology Companion Diagnostic Market Share by End Users (2015-2020)
Table 40. Europe Oncology Companion Diagnostic Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe Oncology Companion Diagnostic Market Share by Country (2015-2020)
Table 42. Asia-Pacific Oncology Companion Diagnostic Market Size by Technology (2015-2020) (US$ Million)
Table 43. Asia-Pacific Oncology Companion Diagnostic Market Share by Technology (2015-2020)
Table 44. Asia-Pacific Oncology Companion Diagnostic Market Size by End Users (2015-2020) (US$ Million)
Table 45. Asia-Pacific Oncology Companion Diagnostic Market Share by End Users (2015-2020)
Table 46. Asia-Pacific Oncology Companion Diagnostic Market Size by Region (US$ Million) (2015-2020)
Table 47. Asia-Pacific Oncology Companion Diagnostic Market Share by Region (2015-2020)
Table 48. Latin America Oncology Companion Diagnostic Market Size by Technology (2015-2020) (US$ Million)
Table 49. Latin America Oncology Companion Diagnostic Market Share by Technology (2015-2020)
Table 50. Latin America Oncology Companion Diagnostic Market Size by End Users (2015-2020) (US$ Million)
Table 51. Latin America Oncology Companion Diagnostic Market Share by End Users (2015-2020)
Table 52. Latin America Oncology Companion Diagnostic Market Size by Country (US$ Million) (2015-2020)
Table 53. Latin America Oncology Companion Diagnostic Market Share by Country (2015-2020)
Table 54. Middle East & Africa Oncology Companion Diagnostic Market Size by Technology (2015-2020) (US$ Million)
Table 55. Middle East & Africa Oncology Companion Diagnostic Market Share by Technology (2015-2020)
Table 56. Middle East & Africa Oncology Companion Diagnostic Market Size by End Users (2015-2020) (US$ Million)
Table 57. Middle East & Africa Oncology Companion Diagnostic Market Share by End Users (2015-2020)
Table 58. Middle East & Africa Oncology Companion Diagnostic Market Size by Country (US$ Million) (2015-2020)
Table 59. Middle East & Africa Oncology Companion Diagnostic Market Share by Country (2015-2020)
Table 60. Agilent Technologies, Inc. Company Details
Table 61. Agilent Technologies, Inc. Business Overview
Table 62. Agilent Technologies, Inc. Oncology Companion Diagnostic Product
Table 63. Agilent Technologies, Inc. Revenue in Oncology Companion Diagnostic Business (2015-2020) (US$ Million)
Table 64. Agilent Technologies, Inc. Recent Development
Table 65. Illumina, Inc. Company Details
Table 66. Illumina, Inc. Business Overview
Table 67. Illumina, Inc. Oncology Companion Diagnostic Product
Table 68. Illumina, Inc. Revenue in Oncology Companion Diagnostic Business (2015-2020) (US$ Million)
Table 69. Illumina, Inc. Recent Development
Table 70. Qiagen N.V. Company Details
Table 71. Qiagen N.V. Business Overview
Table 72. Qiagen N.V. Oncology Companion Diagnostic Product
Table 73. Qiagen N.V. Revenue in Oncology Companion Diagnostic Business (2015-2020) (US$ Million)
Table 74. Qiagen N.V. Recent Development
Table 75. Thermo Fisher Scientific Inc. Company Details
Table 76. Thermo Fisher Scientific Inc. Business Overview
Table 77. Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product
Table 78. Thermo Fisher Scientific Inc. Revenue in Oncology Companion Diagnostic Business (2015-2020) (US$ Million)
Table 79. Thermo Fisher Scientific Inc. Recent Development
Table 80. F. Hoffmann-La Roche Ltd. Company Details
Table 81. F. Hoffmann-La Roche Ltd. Business Overview
Table 82. F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product
Table 83. F. Hoffmann-La Roche Ltd. Revenue in Oncology Companion Diagnostic Business (2015-2020) (US$ Million)
Table 84. F. Hoffmann-La Roche Ltd. Recent Development
Table 85. ARUP Laboratories Company Details
Table 86. ARUP Laboratories Business Overview
Table 87. ARUP Laboratories Oncology Companion Diagnostic Product
Table 88. ARUP Laboratories Revenue in Oncology Companion Diagnostic Business (2015-2020) (US$ Million)
Table 89. ARUP Laboratories Recent Development
Table 90. Abbott Company Details
Table 91. Abbott Business Overview
Table 92. Abbott Oncology Companion Diagnostic Product
Table 93. Abbott Revenue in Oncology Companion Diagnostic Business (2015-2020) (US$ Million)
Table 94. Abbott Recent Development
Table 95. Myriad Genetics, Inc. Business Overview
Table 96. Myriad Genetics, Inc. Oncology Companion Diagnostic Product
Table 97. Myriad Genetics, Inc. Company Details
Table 98. Myriad Genetics, Inc. Revenue in Oncology Companion Diagnostic Business (2015-2020) (US$ Million)
Table 99. Myriad Genetics, Inc. Recent Development
Table 100. bioMérieux SA Company Details
Table 101. bioMérieux SA Business Overview
Table 102. bioMérieux SA Oncology Companion Diagnostic Product
Table 103. bioMérieux SA Revenue in Oncology Companion Diagnostic Business (2015-2020) (US$ Million)
Table 104. bioMérieux SA Recent Development
Table 105. Invivoscribe, Inc. Company Details
Table 106. Invivoscribe, Inc. Business Overview
Table 107. Invivoscribe, Inc. Oncology Companion Diagnostic Product
Table 108. Invivoscribe, Inc. Revenue in Oncology Companion Diagnostic Business (2015-2020) (US$ Million)
Table 109. Invivoscribe, Inc. Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Companion Diagnostic Market Share by Technology: 2020 VS 2026
Figure 2. Polymerase Chain Reaction (PCR) Features
Figure 3. Next-Generation Sequencing (NGS) Features
Figure 4. Immunohistochemistry (IHC) Features
Figure 5. In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH) Features
Figure 6. Others Features
Figure 7. Global Oncology Companion Diagnostic Market Share by End Users: 2020 VS 2026
Figure 8. Hospital Case Studies
Figure 9. Pathology/Diagnostic Laboratory Case Studies
Figure 10. Academic Medical Center Case Studies
Figure 11. Oncology Companion Diagnostic Report Years Considered
Figure 12. Global Oncology Companion Diagnostic Market Size (US$ Million), YoY Growth 2015-2026
Figure 13. Global Oncology Companion Diagnostic Market Share by Regions: 2020 VS 2026
Figure 14. Global Oncology Companion Diagnostic Market Share by Regions (2021-2026)
Figure 15. Global Oncology Companion Diagnostic Market Share by Players in 2019
Figure 16. Global Top Oncology Companion Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Companion Diagnostic as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Oncology Companion Diagnostic Revenue in 2019
Figure 18. North America Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. United States Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Canada Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Europe Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Germany Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. France Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. U.K. Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Italy Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Russia Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Nordic Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Agilent Technologies, Inc. Revenue Growth Rate in Oncology Companion Diagnostic Business (2015-2020)
Figure 44. Illumina, Inc. Revenue Growth Rate in Oncology Companion Diagnostic Business (2015-2020)
Figure 45. Qiagen N.V. Revenue Growth Rate in Oncology Companion Diagnostic Business (2015-2020)
Figure 46. Thermo Fisher Scientific Inc. Revenue Growth Rate in Oncology Companion Diagnostic Business (2015-2020)
Figure 47. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Oncology Companion Diagnostic Business (2015-2020)
Figure 48. ARUP Laboratories Revenue Growth Rate in Oncology Companion Diagnostic Business (2015-2020)
Figure 49. Abbott Revenue Growth Rate in Oncology Companion Diagnostic Business (2015-2020)
Figure 50. Myriad Genetics, Inc. Revenue Growth Rate in Oncology Companion Diagnostic Business (2015-2020)
Figure 51. bioMérieux SA Revenue Growth Rate in Oncology Companion Diagnostic Business (2015-2020)
Figure 52. Invivoscribe, Inc. Revenue Growth Rate in Oncology Companion Diagnostic Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs